3.50
-0.12 (-3.31%)
| Penutupan Terdahulu | 3.62 |
| Buka | 3.63 |
| Jumlah Dagangan | 196,928 |
| Purata Dagangan (3B) | 647,685 |
| Modal Pasaran | 94,566,272 |
| Harga / Pendapatan (P/E Ke hadapan) | 4.82 |
| Harga / Jualan (P/S) | 1.30 |
| Harga / Buku (P/B) | 11.77 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 6 Nov 2025 |
| Margin Keuntungan | -79.61% |
| Margin Operasi (TTM) | -63.88% |
| EPS Cair (TTM) | -2.19 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 66.70% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 1,022.12% |
| Nisbah Semasa (MRQ) | 2.09 |
| Aliran Tunai Operasi (OCF TTM) | -38.38 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -149.68 M |
| Pulangan Atas Aset (ROA TTM) | -38.35% |
| Pulangan Atas Ekuiti (ROE TTM) | -407.50% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Devices (US) | Bercampur | Bercampur |
| Medical Devices (Global) | Bercampur | Bercampur | |
| Stok | Avita Medical, Inc. | Menurun | Menurun |
AISkor Stockmoo
| Konsensus Penganalisis | 1.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 0.5 |
| Purata Bergerak Teknikal | 1.5 |
| Osilator Teknikal | -0.5 |
| Purata | 0.63 |
|
Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently in rollout across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US. |
|
| Sektor | Healthcare |
| Industri | Medical Devices |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 0.83% |
| % Dimiliki oleh Institusi | 26.79% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 10.00 (D. Boral Capital, 185.71%) | Beli |
| Median | 6.75 (92.86%) | |
| Rendah | 3.50 (Lake Street, 0.00%) | Pegang |
| Purata | 6.75 (92.86%) | |
| Jumlah | 1 Beli, 1 Pegang | |
| Harga Purata @ Panggilan | 3.46 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Lake Street | 16 Jan 2026 | 3.50 (0.00%) | Pegang | 3.46 |
| 17 Oct 2025 | 4.00 (14.29%) | Pegang | 3.99 | |
| D. Boral Capital | 15 Jan 2026 | 10.00 (185.71%) | Beli | 3.46 |
| 07 Nov 2025 | 14.00 (300.00%) | Beli | 3.77 |
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 13 Jan 2026 | Pengumuman | AVITA Medical: Pre-J.P. Morgan Update Highlights 2025 Revenue Growth, New Debt Facility, and 2026 Growth Outlook |
| 05 Jan 2026 | Pengumuman | AVITA Medical Announces Changes to its Board of Directors |
| 18 Dec 2025 | Pengumuman | AVITA Medical to Present at the 44th Annual J.P. Morgan Healthcare Conference |
| 24 Nov 2025 | Pengumuman | AVITA Medical to Present at the Piper Sandler 37ᵗʰ Annual Healthcare Conference |
| 09 Nov 2025 | Pengumuman | AVITA Medical to Host Investor Webinar Briefing |
| 06 Nov 2025 | Pengumuman | AVITA® Medical Reports Third Quarter 2025 Financial Results |
| 03 Nov 2025 | Pengumuman | Data Presented at the 2025 Southern Region Burn Conference Reinforce RECELL® System as a Standard of Care in Acute Wound Treatment |
| 29 Oct 2025 | Pengumuman | AVITA Medical to Announce Third Quarter 2025 Financial Results |
| 28 Oct 2025 | Pengumuman | AVITA Medical Welcomes Support for RECELL® in Burns in Australia |
| 16 Oct 2025 | Pengumuman | AVITA Medical Announces CEO Transition |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |